Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment
Authors:
- 1 January 2020
- book chapter
- Published by Elsevier
- Vol. 147, 1-57
Abstract
No abstract availableKeywords
This publication has 278 references indexed in Scilit:
- Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A GenesPLOS ONE, 2013
- EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesisActa Neuropathologica, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer DevelopmentCell, 2011
- Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapyEuropean Journal of Cancer, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR EndocytosisCurrent Biology, 2009
- Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane SegmentCell, 2009
- Receptor tyrosine kinases: mechanisms of activation and signalingCurrent Opinion in Cell Biology, 2007
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006